ID   ALG11_HUMAN             Reviewed;         492 AA.
AC   Q2TAA5; A5PLP3; B4DKW9; Q5TAN9; Q6DKI6; Q96FI7;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 2.
DT   28-JUN-2023, entry version 142.
DE   RecName: Full=GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase;
DE            EC=2.4.1.131;
DE   AltName: Full=Asparagine-linked glycosylation protein 11 homolog;
DE   AltName: Full=Glycolipid 2-alpha-mannosyltransferase;
GN   Name=ALG11; Synonyms=GT8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, VARIANT CDG1P SER-86,
RP   CHARACTERIZATION OF VARIANT CDG1P SER-86, AND MUTAGENESIS OF LEU-86.
RX   PubMed=20080937; DOI=10.1093/hmg/ddq016;
RA   Rind N., Schmeiser V., Thiel C., Absmanner B., Lubbehusen J., Hocks J.,
RA   Apeshiotis N., Wilichowski E., Lehle L., Korner C.;
RT   "A severe human metabolic disease caused by deficiency of the endoplasmatic
RT   mannosyltransferase hALG11 leads to congenital disorder of glycosylation-
RT   Ip.";
RL   Hum. Mol. Genet. 19:1413-1424(2010).
RN   [5]
RP   VARIANTS CDG1P SER-279; PRO-318; SER-381 AND LYS-398.
RX   PubMed=22213132; DOI=10.1002/humu.22019;
RA   Thiel C., Rind N., Popovici D., Hoffmann G.F., Hanson K., Conway R.L.,
RA   Adamski C.R., Butler E., Scanlon R., Lambert M., Apeshiotis N., Thiels C.,
RA   Matthijs G., Korner C.;
RT   "Improved diagnostics lead to identification of three new patients with
RT   congenital disorder of glycosylation-Ip.";
RL   Hum. Mutat. 33:485-487(2012).
CC   -!- FUNCTION: Mannosyltransferase involved in the last steps of the
CC       synthesis of Man5GlcNAc(2)-PP-dolichol core oligosaccharide on the
CC       cytoplasmic face of the endoplasmic reticulum. Catalyzes the addition
CC       of the 4th and 5th mannose residues to the dolichol-linked
CC       oligosaccharide chain. {ECO:0000269|PubMed:20080937}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-
CC         beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphosphodolichol + 2 GDP-alpha-
CC         D-mannose = alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-
CC         [alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-
CC         GlcNAc-diphosphodolichol + 2 GDP + 2 H(+); Xref=Rhea:RHEA:29523,
CC         Rhea:RHEA-COMP:12626, Rhea:RHEA-COMP:12627, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57527, ChEBI:CHEBI:58189, ChEBI:CHEBI:132511,
CC         ChEBI:CHEBI:132515; EC=2.4.1.131;
CC         Evidence={ECO:0000269|PubMed:20080937};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:20080937}. Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:20080937}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:20080937}.
CC   -!- DISEASE: Congenital disorder of glycosylation 1P (CDG1P) [MIM:613661]:
CC       A form of congenital disorder of glycosylation, a multisystem disorder
CC       caused by a defect in glycoprotein biosynthesis and characterized by
CC       under-glycosylated serum glycoproteins. Congenital disorders of
CC       glycosylation result in a wide variety of clinical features, such as
CC       defects in the nervous system development, psychomotor retardation,
CC       dysmorphic features, hypotonia, coagulation disorders, and
CC       immunodeficiency. The broad spectrum of features reflects the critical
CC       role of N-glycoproteins during embryonic development, differentiation,
CC       and maintenance of cell functions. {ECO:0000269|PubMed:20080937,
CC       ECO:0000269|PubMed:22213132}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase group 1 family.
CC       Glycosyltransferase 4 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI11023.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK296747; BAG59331.1; -; mRNA.
DR   EMBL; AL139082; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC073862; AAH73862.1; -; mRNA.
DR   EMBL; BC010857; AAH10857.3; -; mRNA.
DR   EMBL; BC111022; AAI11023.1; ALT_SEQ; mRNA.
DR   EMBL; BC142998; AAI42999.1; -; mRNA.
DR   CCDS; CCDS31977.1; -.
DR   RefSeq; NP_001004127.2; NM_001004127.2.
DR   AlphaFoldDB; Q2TAA5; -.
DR   SMR; Q2TAA5; -.
DR   BioGRID; 136328; 95.
DR   IntAct; Q2TAA5; 8.
DR   STRING; 9606.ENSP00000430236; -.
DR   CAZy; GT4; Glycosyltransferase Family 4.
DR   GlyCosmos; Q2TAA5; 2 sites, No reported glycans.
DR   GlyGen; Q2TAA5; 3 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q2TAA5; -.
DR   PhosphoSitePlus; Q2TAA5; -.
DR   SwissPalm; Q2TAA5; -.
DR   BioMuta; ALG11; -.
DR   DMDM; 156631015; -.
DR   EPD; Q2TAA5; -.
DR   jPOST; Q2TAA5; -.
DR   MassIVE; Q2TAA5; -.
DR   MaxQB; Q2TAA5; -.
DR   PaxDb; Q2TAA5; -.
DR   PeptideAtlas; Q2TAA5; -.
DR   ProteomicsDB; 61454; -.
DR   Antibodypedia; 49847; 238 antibodies from 19 providers.
DR   DNASU; 440138; -.
DR   Ensembl; ENST00000521508.2; ENSP00000430236.1; ENSG00000253710.5.
DR   GeneID; 440138; -.
DR   KEGG; hsa:440138; -.
DR   MANE-Select; ENST00000521508.2; ENSP00000430236.1; NM_001004127.3; NP_001004127.2.
DR   UCSC; uc001vga.4; human.
DR   AGR; HGNC:32456; -.
DR   CTD; 440138; -.
DR   DisGeNET; 440138; -.
DR   GeneCards; ALG11; -.
DR   GeneReviews; ALG11; -.
DR   HGNC; HGNC:32456; ALG11.
DR   HPA; ENSG00000253710; Low tissue specificity.
DR   MalaCards; ALG11; -.
DR   MIM; 613661; phenotype.
DR   MIM; 613666; gene.
DR   neXtProt; NX_Q2TAA5; -.
DR   OpenTargets; ENSG00000253710; -.
DR   Orphanet; 280071; ALG11-CDG.
DR   VEuPathDB; HostDB:ENSG00000253710; -.
DR   eggNOG; KOG1387; Eukaryota.
DR   GeneTree; ENSGT00550000075118; -.
DR   HOGENOM; CLU_017896_2_0_1; -.
DR   InParanoid; Q2TAA5; -.
DR   OMA; ARLYGWV; -.
DR   OrthoDB; 197751at2759; -.
DR   PhylomeDB; Q2TAA5; -.
DR   TreeFam; TF313056; -.
DR   BRENDA; 2.4.1.131; 2681.
DR   PathwayCommons; Q2TAA5; -.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   Reactome; R-HSA-4551295; Defective ALG11 causes CDG-1p.
DR   SignaLink; Q2TAA5; -.
DR   SIGNOR; Q2TAA5; -.
DR   BioGRID-ORCS; 440138; 793 hits in 1169 CRISPR screens.
DR   ChiTaRS; ALG11; human.
DR   GeneWiki; ALG11; -.
DR   GenomeRNAi; 440138; -.
DR   Pharos; Q2TAA5; Tbio.
DR   PRO; PR:Q2TAA5; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q2TAA5; protein.
DR   Bgee; ENSG00000253710; Expressed in islet of Langerhans and 112 other tissues.
DR   ExpressionAtlas; Q2TAA5; baseline and differential.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0000026; F:alpha-1,2-mannosyltransferase activity; TAS:Reactome.
DR   GO; GO:0004377; F:GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0006490; P:oligosaccharide-lipid intermediate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IBA:GO_Central.
DR   CDD; cd03806; GT4_ALG11-like; 1.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 1.
DR   InterPro; IPR038013; ALG11.
DR   InterPro; IPR031814; ALG11_N.
DR   InterPro; IPR001296; Glyco_trans_1.
DR   PANTHER; PTHR45919; GDP-MAN:MAN(3)GLCNAC(2)-PP-DOL ALPHA-1,2-MANNOSYLTRANSFERASE; 1.
DR   PANTHER; PTHR45919:SF1; GDP-MAN:MAN(3)GLCNAC(2)-PP-DOL ALPHA-1,2-MANNOSYLTRANSFERASE; 1.
DR   Pfam; PF15924; ALG11_N; 1.
DR   Pfam; PF00534; Glycos_transf_1; 1.
DR   SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1.
PE   1: Evidence at protein level;
KW   Congenital disorder of glycosylation; Disease variant;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase; Membrane;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..492
FT                   /note="GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-
FT                   mannosyltransferase"
FT                   /id="PRO_0000295616"
FT   TRANSMEM        20..40
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        234..254
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        273
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         86
FT                   /note="L -> S (in CDG1P; does not affect subcellular
FT                   localization; results in the accumulation of
FT                   under-glycosylated proteins; dbSNP:rs267606652)"
FT                   /evidence="ECO:0000269|PubMed:20080937"
FT                   /id="VAR_064908"
FT   VARIANT         108
FT                   /note="N -> S (in dbSNP:rs17480245)"
FT                   /id="VAR_055902"
FT   VARIANT         279
FT                   /note="Y -> S (in CDG1P; dbSNP:rs387907181)"
FT                   /evidence="ECO:0000269|PubMed:22213132"
FT                   /id="VAR_068070"
FT   VARIANT         318
FT                   /note="Q -> P (in CDG1P; dbSNP:rs387907184)"
FT                   /evidence="ECO:0000269|PubMed:22213132"
FT                   /id="VAR_068071"
FT   VARIANT         381
FT                   /note="L -> S (in CDG1P; dbSNP:rs387907182)"
FT                   /evidence="ECO:0000269|PubMed:22213132"
FT                   /id="VAR_068072"
FT   VARIANT         398
FT                   /note="E -> K (in CDG1P; dbSNP:rs387907183)"
FT                   /evidence="ECO:0000269|PubMed:22213132"
FT                   /id="VAR_068073"
FT   MUTAGEN         86
FT                   /note="L->A: Does not affect function."
FT                   /evidence="ECO:0000269|PubMed:20080937"
FT   MUTAGEN         86
FT                   /note="L->P: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:20080937"
FT   CONFLICT        96
FT                   /note="A -> V (in Ref. 3; AAI42999)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   492 AA;  55651 MW;  1B3B0789030777FC CRC64;
     MAAGERSWCL CKLLRFFYSL FFPGLIVCGT LCVCLVIVLW GIRLLLQRKK KLVSTSKNGK
     NQMVIAFFHP YCNAGGGGER VLWCALRALQ KKYPEAVYVV YTGDVNVNGQ QILEGAFRRF
     NIRLIHPVQF VFLRKRYLVE DSLYPHFTLL GQSLGSIFLG WEALMQCVPD VYIDSMGYAF
     TLPLFKYIGG CQVGSYVHYP TISTDMLSVV KNQNIGFNNA AFITRNPFLS KVKLIYYYLF
     AFIYGLVGSC SDVVMVNSSW TLNHILSLWK VGNCTNIVYP PCDVQTFLDI PLHEKKMTPG
     HLLVSVGQFR PEKNHPLQIR AFAKLLNKKM VESPPSLKLV LIGGCRNKDD ELRVNQLRRL
     SEDLGVQEYV EFKINIPFDE LKNYLSEATI GLHTMWNEHF GIGVVECMAA GTIILAHNSG
     GPKLDIVVPH EGDITGFLAE SEEDYAETIA HILSMSAEKR LQIRKSARAS VSRFSDQEFE
     VTFLSSVEKL FK
//
